1-anilino-8-naphthalenesulfonate has been researched along with Essential Hypertension in 2 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Essential Hypertension: Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity is an emerging risk factor for chronic kidney disease (CKD) in the developed world." | 1.39 | Orlistat, an under-recognised cause of progressive renal impairment. ( Coutinho, AK; Glancey, GR, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coutinho, AK | 1 |
| Glancey, GR | 1 |
| CREPALDI, G | 1 |
| AVOGARO, P | 1 |
| BEATRICE, L | 1 |
2 other studies available for 1-anilino-8-naphthalenesulfonate and Essential Hypertension
| Article | Year |
|---|---|
Orlistat, an under-recognised cause of progressive renal impairment.
Topics: Acute Kidney Injury; Aged; Anti-Obesity Agents; Diabetes Mellitus, Type 2; Disease Progression; Esse | 2013 |
[The behavior of lipoprotein lipase in essential hypertension].
Topics: Essential Hypertension; Humans; Hypertension; Lipase; Lipoprotein Lipase | 1960 |